Drugs / Esculin and Digitalisglycosides
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07151612 | Sep → Oct 2025 | presbyopia | Shanxi Eye Hospital | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Esculin and Digitalisglycosides | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07151612 ↗ |
| Route | Topical | “apply 1 drop to the affected eye three times a day” NCT07151612 ↗ |